Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.36 USD | -1.33% | -13.37% | -47.29% |
05-09 | Gyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-03 | Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing | MT |
- Stock Market
- Equities
- GYRE Stock
- News Gyre Therapeutics, Inc.
- MarketScreener Strategies